ACCESS & STRATEGY
AccessCore believes that access to medicines and innovative solutions matches the importance of the scientific advancement itself.
To reach successful access and keep pace with the evolving healthcare market landscape, our experts bring local capabilities to global standards and provide you with a comprehensive approach based on the evolution, shifts and drivers of the healthcare system and market.
With our implementation expertise, AccessCore supports you throughout every step of the way, delivering the tools that help you communicate and capture value.
Our Access and Strategy services include:
Pricing tool
Our In-depth knowledge of the healthcare system (Lebanon, Syria, KSA, UAE, Jordan, Egypt, Iraq, and Iran) is the cornerstone we depend on when conducting Payer research and setting an outline of requirements for launch. We provide country-specific pharma pricing and international reference pricing through Two Scenarios Pricing Tool – International Reference PRICING Model IRENE
- Reimbursement solutions
AccessCore’s rigorous understanding of the clinical and economic burden of pharma products allows it to build strategic reimbursement roadmaps that address everything including policy, pricing, and evidence development.
Our value communication tools are developed by pricing and market access specialists who have experience in clinical development and health economics.
Based on their analysis, our experts provide insights on how your product may fit into therapeutic strategies and attend to needs.
They craft value stories that convey messages and evidence in a clear and concise way to ensure that payers and price-sensitive customers will be convinced of the value that your product provides over other therapies available in the market.
Payer Environment Assessment
To have a realistic assessment of the best price and access situation that can be achieved and maintained, AccessCore crafts country-based assessment using a range of approaches depending on your needs at different stages of the development and life of your product.
Our experts will work closely with you to ensure that the approach used addresses the issues that are important for your product.
Health Technology Assessment (HTA)
AccessCore provides systematic evaluation of the properties, effects and impacts of your product.
Our HTA health economics and outcomes research covers both the direct, intended consequences of the product as well as its indirect, unintended consequences.
To achieve optimal Market Access, our experts work with you across the different stages of your health intervention lifecycle: Before full scale development to consider new opportunities, during phase II to define early strategy and support needs, at phase III where unique features of a medicine/ product can be converted into a robust value proposition, and even at the final stages after loss of exclusivity.
Early development
- Market, competitor and payer landscaping
- Payer insights on go-no-go decision making and investment requirements
- Payer needs assessment
- Price & Market Access achievable
- Evidence requirements
Late development
- Payer value drivers and Price and Market Access positioning strategies
- Payer value proposition and value message development
- Evidence generation strategies
- Payer value and evidence packs
Launch
- Price and Market Access strategy development
- Launch pricing strategies
- Contracting strategies
- Competitor strategies
- Launch pricing strategies
- Policy strategies/initiatives
Life Cycle & Loss Of Exclusivity (LOE)
- Life cycle management strategies – new indications, markets, geographies
- Competitor response strategies
- Price/access/uptake benchmarking and assessments
- LOE strategies